SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " biontech " 4 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Lilly, BioNTech Warn German Health Reforms Could Hurt Investment
Eli Lilly & Co. and BioNTech SE joined a growing chorus of drugmakers warning that proposed healthcare reforms in Germany risk undermining investment the country.
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
Biopharma companies—including AstraZeneca, BioNTech and Agios—peered farther into the future on the second day of JPM, setting both revenue and R&D targets through the end of the decade.
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time gene therapy for Sanfilippo syndrome type A, an inherited disease that progressively destroys cognitive function in young children. Until this week, there was no approved treatment at all. BioNTech’s lung cancer candidate shows promising results. […]
Vikas Sehdev: Starting a New Chapter as Senior Medical Science Liaison at BioNTech SE
Vikas Sehdev: Starting a New Chapter as Senior Medical Science Liaison at BioNTech SE / AstraZeneca, BioNTech SE, cancer, OncoDaily, Oncology, Vikas Sehdev